Viking Therapeutics (VKTX) Tops Q4 EPS by 3c

Viking Therapeutics (NASDAQ: VKTX) reported Q4 EPS of ($0.16), $0.03 better than the analyst estimate of ($0.19).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• CoStar Group acquires Zonda for $800M, adding new home data
• The Buckle (BKE) Tops Q2 EPS by 7c, Beats on Revenue